Prestige Consumer Healthcare (PBH) Property, Plant & Equipment (Net) Growth (1y) (2012 - 2026)
Prestige Consumer Healthcare (PBH) Property, Plant & Equipment (Net) Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | -18.34% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 6.19% |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | -0.59% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 41.67% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -7.68% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | -1.31% |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 3.98% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | 3.94% |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.36 Bn | - | 63.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.24% |
| Dec 31, 2025 | 74.38% |
| Sep 30, 2025 | -2.43% |
| Jun 30, 2025 | -2.15% |
| Mar 31, 2025 | -2.56% |
| Dec 31, 2024 | 4.50% |
| Sep 30, 2024 | 5.97% |
| Jun 30, 2024 | 7.76% |
| Mar 31, 2024 | 8.66% |
| Dec 31, 2023 | 1.13% |
| Sep 30, 2023 | 1.08% |
| Jun 30, 2023 | -0.59% |
| Mar 31, 2023 | -1.25% |
| Dec 31, 2022 | -0.34% |
| Sep 30, 2022 | -0.11% |
| Jun 30, 2022 | 0.81% |
| Mar 31, 2022 | 1.77% |
| Dec 31, 2021 | 1.73% |
| Sep 30, 2021 | 7.46% |
| Jun 30, 2021 | 19.72% |